China SXT Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $21.7M
Liabilities Breakdown FY2020
Total Liabilities: $12.3M
Asset Breakdown
Total Assets: $21.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.3M | 33.6% |
| Accounts Receivable | $3.8M | 17.6% |
| Inventory | $892.8K | 4.1% |
| Property, Plant & Equipment | $1.6M | 7.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $50.1K | 0.2% |
| Other Assets | $8.1M | 37.2% |
Liabilities Breakdown
Total Liabilities: $12.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 15.8% |
| Long-Term Debt | $36.5K | 0.3% |
| Other Liabilities | $10.3M | 83.9% |